England expands HPV home-testing offer
The NHS will offer free HPV self-testing kits to nearly four million women who have missed cervical screening invitations over the next year.
The 60-second version
England is offering free HPV self-testing kits to nearly four million women who missed screening, with clinical follow-up still required after a positive result.
Key points
- The kit uses a self-collected vaginal swab returned to the NHS.
- High-risk HPV raises cancer risk but does not diagnose cervical cancer.
- The NHS says clinician screening remains the best preventive pathway.
- Real-world success will depend on kit returns and completed follow-up.
Verdict. Home testing can widen access, but it works as the first step in a screening pathway, not as a replacement for clinical care.
The programmeThe programme
Women in England who have missed a cervical screening appointment will be invited to order a free HPV self-testing kit through the NHS App, text, email or letter. The rollout is expected to reach nearly four million people over the next year.
What the kit can and cannot tell youWhat the kit can and cannot tell you
The kit uses a vaginal swab that is returned to the NHS. It looks for high-risk human papillomavirus, a virus responsible for nearly all cervical cancers. A positive result indicates increased risk, not a diagnosis. People with high-risk HPV will be invited to book a follow-up cervical screening appointment.
Why access mattersWhy access matters
Cervical cancer may have no symptoms until it is more advanced. Home sampling is therefore an access intervention: it is designed to help people who face embarrassment, time pressure, discomfort or difficulty attending an appointment.
The clinical boundaryThe clinical boundary
| Home kit | A self-collected sample is tested for high-risk HPV. |
|---|---|
| Positive result | Follow-up clinician screening is required; HPV is not the same as cancer. |
| Clinician appointment | The NHS says an appointment remains the best way to prevent cervical cancer. |
| Vaccination | HPV vaccination and screening work together in the elimination strategy. |
The home option should not be read as a replacement for every clinical appointment. Its value is getting more people into the pathway, then routing abnormal or positive findings to appropriate care.
What the evidence saysWhat the evidence says
London trials suggest self-testing could bring roughly one in ten invited women forward, potentially increasing participation by around 400,000 a year. Those are programme estimates and should be assessed against real-world return rates, laboratory capacity and follow-up completion as the rollout expands.
Bottom lineBottom line
The home kit lowers the first barrier; it does not remove the need for screening follow-up.
Anyone receiving an invitation should follow the instructions and contact the NHS if they are unsure what happens after a result. Screening is preventive care, not a test reserved for people who already have symptoms.
Primary sourcesNHS cervical screening guidance·BBC News